TECOGEN INC. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on April 15, 2016, covering events that occurred on April 11, 2016, and April 13, 2016. The filing details a corporate transaction involving Tecogen Inc. and its majority-owned subsidiary, Ilios Inc.
Key Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a specific equity transaction.
Material Changes
The Company entered into private placement share exchange agreements with shareholders of Ilios Inc. Key terms include:
- Exchange Ratio: Shareholders exchanged every 7.86 restricted Ilios shares for 1 share of Tecogen Inc. restricted common stock.
- Shares Issued: Tecogen issued 559,783 shares on April 11, 2016, and 16,538 shares on April 13, 2016, totaling 576,321 shares.
- Registration Rights: The Company granted registration rights for the Tecogen common stock received by the exchanging shareholders.
- Regulatory Basis: The transaction was conducted as a private placement without registration under the Securities Act of 1933, relying on exemptions under Section 4(a)(2) and/or Regulation D.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure that the transaction was unregistered. Additional information is referenced in a press release dated April 12, 2016 (Exhibit 99.1).
Investor Verification Checklist
- Verify the total number of Tecogen shares issued (576,321) and the impact on total outstanding shares.
- Review the full Share Exchange Agreement (Exhibit 10.35) for covenants or restrictions on the exchanged shares.
- Examine the press release (Exhibit 99.1) for strategic rationale regarding the Ilios subsidiary.
- Confirm the status of the registration rights granted to the exchanging shareholders.